Polysan to build one of the largest drugmaking facilities in the North-West Russia

The Russian pharmaceutical company Polysan will build one of the largest drugmaking facilities in the North-West of Russia, that will be located on the Sofiysky industrial park in St Petersburg.

Under the terms of the project, which was approved during the recent St Petersburg International Economic Forum, the value of the investment will amount to at least 3.5 billion roubles ($45 million). The plant is planned to be built within five years.

The enterprise will create 150 jobs at the initial stage. The new plant will focus on the production of some original drugs of Polysan, such as an anti-viral drug Cycloferon, Cytoflavin (intended for the treatment of brain dysfunctions and restoration of cerebral circulation), Reamberin (prevents exogenous and endogenous intoxications of various etiologies) and Remaxol (complex treats liver diseases).